Spyros was Chief Business Officer at Vigil Neuroscience, and Chief Development Officer at Acadia Pharmaceuticals. Spyros Papapetropoulos joined Lipocine in 2022.
Spyros Papapetropoulos is currently Director at Lipocine - View - Lipocine org chart
Create your alert
to follow the career of Spyros Papapetropoulos.
In 1997, Spyros Papapetropoulos completed a PhD in Medicine at University of Patras.
Do you need to know more about Spyros Papapetropoulos? More results.
Report an error
Update the org chart details of Spyros Papapetropoulos.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.